For example, DPP-IV inhibitory peptides could be co-encapsulated with other active compounds that have been demonstrated to be beneficial for diabetes prevention and treatment, such as α-glucosidase inhibitors, specific polysaccharides, flavonoids, or polyphenols. This evidence concerns the gene DPP4 and diabetes mellitus.